Worldwide shipping · 120+ destinationsCOA & GHS SDS with every lotMon–Sat, 09:30–18:30 IST
VAQORACHEMICALS
Product division

Impurities & Reference Standards

Pharmacopoeial and non-pharmacopoeial impurities, metabolites, nitrosamines and working standards with characterisation data for QC and regulatory work.

27,990products
6sub-categories
2,746in stock
COA + SDSwith every lot
27,990 results · page 182 of 1167
GridList
Reference Standard
2-Nitrosopyridine chemical structure
2-Nitrosopyridine
CAS
79917-37-6
Formula
C5H4N2O
MW
108.1 g/mol
VQ-039649
Reference Standard
2-Nonenedioic Acid chemical structure
2-Nonenedioic Acid
CAS
72461-80-4
Formula
C9H14O4
MW
186.2 g/mol
VQ-021696
Reference Standard
2-Nor Bimatoprost chemical structure
2-Nor Bimatoprost
CAS
1356251-65-4
Formula
C24H35NO4
MW
401.5 g/mol
VQ-024595
Reference Standard
2-NP-AHD chemical structure
2-NP-AHD
CAS
623145-57-3
Formula
C10H8N4O4
MW
248.19 g/mol
VQ-040708
Reference Standard
2-Np-ahd-13C3 chemical structure
2-Np-ahd-13C3
CAS
1007476-86-9
Formula
C10H8N4O4
MW
251.17 g/mol
VQ-049264
Reference Standard
2-Np-amoz chemical structure
2-Np-amoz
CAS
183193-59-1
Formula
C15H18N4O5
MW
334.33 g/mol
VQ-038675
Reference Standard
2-Np-Sca-13C,15N2 chemical structure
2-Np-Sca-13C,15N2
CAS
957509-32-9
Formula
C8H8N4O3
MW
211.15 g/mol
VQ-041223
Reference Standard
2-Oxo Ifosfamide chemical structure
2-Oxo Ifosfamide
CAS
119670-13-2
Formula
C7H13Cl2N2O3P
MW
275.07 g/mol
VQ-022824
Reference Standard
2-Oxo R-Clopidogrel chemical structure
2-Oxo R-Clopidogrel
CAS
1360923-54-1
Formula
C16H16ClNO3S
MW
337.8 g/mol
VQ-029898
Reference Standard
2-Oxo-Ivabradine chemical structure
2-Oxo-Ivabradine
CAS
1616710-52-1
Formula
C27H34N2O6
MW
482.6 g/mol
VQ-026265
Reference Standard
2-Oxymoxifloxacin chemical structure
2-Oxymoxifloxacin
CAS
1395056-41-3
Formula
C21H22FN3O5
MW
415.4 g/mol
VQ-026788

Need a price, a spec or a custom compound?

Send us your list — product names or CAS numbers, grade, quantity and destination. Our team replies with a formal quotation, COA and lead time.